U.S. Physical Therapy (DB:UPH) - Cotización, noticias y análisis

Resumen de acción UPH

U.S. Physical Therapy, Inc. gestiona clínicas de fisioterapia ambulatoria.

UPH fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	4/6
Past Performance	1/6
Financial Health	4/6
Dividends	3/6

Recompensas

Cotiza un 16.9% por debajo de nuestra estimación de su valor justo

Se prevé un crecimiento anual de los beneficios de 26.87%

Análisis de riesgos

El dividendo de 1.67% no está bien cubierto por los beneficios

Grandes partidas extraordinarias que afectan a los resultados financieros

Los accionistas han sido diluidos en el último año

Los márgenes de beneficio (3%) son inferiores a los del año pasado (5.3%)

+ 1 riesgos adicionales

Competidores de U.S. Physical Therapy, Inc.

RHÖN-KLINIKUM

XTRA:RHK

€830.0m

M1 Kliniken

XTRA:M12

€288.5m

LIMES Schlosskliniken

XTRA:LIK

€101.4m

Gesundheitswelt Chiemgau

MUN:JTH

€22.4m

Historial de precios y rendimiento

Summary of all time highs, changes and price drops for U.S. Physical Therapy
Historical stock prices
Current Share Price	US$96.00
52 Week High	US$111.00
52 Week Low	US$75.50
Beta	1.38
1 Month Change	-0.52%
3 Month Change	10.34%
1 Year Change	-2.04%
3 Year Change	-0.52%
5 Year Change	-7.59%
Change since IPO	640.74%

Noticias y actualizaciones recientes

Recent updates

Rentabilidad de los accionistas

	UPH	DE Healthcare	Mercado DE
7D	3.2%	3.1%	-1.0%
1Y	-2.0%	2.0%	2.0%

Rentabilidad vs. Industria: Los resultados de UPH fueron inferiores a los de la industria German Healthcare, que obtuvo un rendimiento del 2.1% el año pasado.

Rentabilidad vs. Mercado: UPH obtuvo unos resultados inferiores a los del mercado German, que fue del 2.3% el año pasado.

Volatilidad de los precios

Is UPH's price volatile compared to industry and market?
UPH volatility
UPH Average Weekly Movement	4.1%
Healthcare Industry Average Movement	5.9%
Market Average Movement	4.9%
10% most volatile stocks in DE Market	10.2%
10% least volatile stocks in DE Market	2.4%

Precio estable de las acciones: UPH no ha tenido una volatilidad de precios significativa en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de UPH (4%) se ha mantenido estable durante el año pasado.

Acerca de la empresa

Fundada	Empleados	CEO	Página web
1990	5,310	Chris Reading	www.usph.com

U.S. Physical Therapy, Inc. gestiona clínicas de fisioterapia ambulatoria. La empresa opera a través de los segmentos Physical Therapy Operations e Industrial Injury Prevention Services. La empresa proporciona cuidados y tratamientos pre y postoperatorios para trastornos ortopédicos, lesiones deportivas, cuidados preventivos, rehabilitación de trabajadores lesionados y lesiones neurológicas.

Resumen de fundamentos de U.S. Physical Therapy, Inc.

¿Cómo se comparan los beneficios e ingresos de U.S. Physical Therapy con su capitalización de mercado?
Estadísticas fundamentales de UPH
Capitalización bursátil	€1.47b
Beneficios(TTM)	€16.85m
Ingresos (TTM)	€556.07m

87.4x

Ratio precio-beneficio (PE)

2.6x

Ratio precio-ventas (PS)

¿Está UPH sobrevalorada?

Ver valor justo y análisis de valoración

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de UPH
Ingresos	US$598.63m
Coste de los ingresos	US$477.12m
Beneficio bruto	US$121.51m
Otros gastos	US$103.37m
Beneficios	US$18.14m

Últimos beneficios comunicados

Dec 31, 2023

Próxima fecha de beneficios

May 07, 2024

Beneficios por acción (BPA)	1.20
Margen bruto	20.30%
Margen de beneficio neto	3.03%
Ratio deuda/patrimonio	22.5%

¿Cómo se ha desempeñado UPH a largo plazo?

Ver rendimiento histórico y comparativa

Dividendos

1.7%

Rentabilidad actual por dividendo

135%

Ratio de pagos

Resumen de acción UPH

Recompensas

Análisis de riesgos

Competidores de U.S. Physical Therapy, Inc.

XTRA:RHK

€830.0m

XTRA:M12

€288.5m

XTRA:LIK

€101.4m

MUN:JTH

€22.4m

Historial de precios y rendimiento

Noticias y actualizaciones recientes

U.S. Physical Therapy, Inc., Annual General Meeting, May 21, 2024

Chief Operating Officer - West recently sold €253k worth of stock

Fourth quarter dividend of US$0.44 announced

New minor risk - Profit margin trend

U.S. Physical Therapy, Inc. Increases Quarterly Dividend, Payable on April 5, 2024

New minor risk - Earnings quality

Recent updates

U.S. Physical Therapy, Inc., Annual General Meeting, May 21, 2024

Chief Operating Officer - West recently sold €253k worth of stock

Fourth quarter dividend of US$0.44 announced

New minor risk - Profit margin trend

U.S. Physical Therapy, Inc. Increases Quarterly Dividend, Payable on April 5, 2024

New minor risk - Earnings quality

Full year 2023 earnings released: EPS: US$1.99 (vs US$2.25 in FY 2022)

Now 21% undervalued

U.S. Physical Therapy, Inc. to Report Q4, 2023 Results on Feb 28, 2024

U.S. Physical Therapy, Inc. to Report Q4, 2023 Results on Feb 28, 2024

Now 21% undervalued after recent price drop

Third quarter 2023 earnings released: EPS: US$0.62 (vs US$0.72 in 3Q 2022)

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on December 8, 2023

U.S. Physical Therapy, Inc. to Report Q3, 2023 Results on Nov 07, 2023

Chief Operating Officer - West recently sold €413k worth of stock

Second quarter 2023 earnings released: EPS: US$0.80 (vs US$0.87 in 2Q 2022)

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on September 8, 2023

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired a 70% stake in U.S. Physical Therapy, Inc. (NYSE:USPH) for $2.1 million.

U.S. Physical Therapy, Inc. to Report Q2, 2023 Results on Aug 08, 2023

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired 75% interest in Physical therapy practice with four clinics for $3.1 million

U.S. Physical Therapy, Inc. has completed a Follow-on Equity Offering in the amount of $150.00003 million.

U.S. Physical Therapy, Inc. Elects Nancy Ham to the Board of Directors

Upcoming dividend of US$0.43 per share at 1.6% yield

U.S. Physical Therapy Declares Quarterly Dividend, Payable on June 9, 2023

First quarter 2023 earnings released: EPS: US$0.57 (vs US$0.67 in 1Q 2022)

Independent Director recently sold €439k worth of stock

Executive VP recently sold €87k worth of stock

Upcoming dividend of US$0.43 per share at 1.7% yield

Full year 2022 earnings released: EPS: US$2.25 (vs US$2.42 in FY 2021)

U.S. Physical Therapy, Inc. to Report Q4, 2022 Results on Feb 22, 2023

Independent Director recently sold €573k worth of stock

President recently sold €858k worth of stock

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired 80% stake in Thirteen-clinic physical therapy practice from practice’s owners for $25 million.

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired 80% stake in Thirteen-clinic physical therapy practice for $25 million.

Insufficient new directors

Upcoming dividend of US$0.41 per share

Chief Operating Officer - West recently sold €162k worth of stock

Now 23% undervalued after recent price drop

Third quarter 2022 earnings released: EPS: US$0.73 (vs US$0.66 in 3Q 2021)

U.S. Physical Therapy, Inc. Provides Operating Guidance for 2022

U.S. Physical Therapy, Inc. (NYSE : USPH) acquired 60% stake in Fourteen-clinic physical therapy practice for $19.3 million.

U.S. Physical Therapy, Inc. to Report Q3, 2022 Results on Nov 03, 2022

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired 80% stake in Two-Clinic Physical Therapy Practice for $4.2 million.

Director recently bought €78k worth of stock

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired a 70% stake in six-clinic physical therapy practice in West Virginia and Pennsylvania for $3.5 million.

Independent Director recently bought €82k worth of stock

Independent Director recently bought €54k worth of stock

Second quarter 2022 earnings released: EPS: US$0.86 (vs US$0.82 in 2Q 2021)

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on September 16, 2022

U.S. Physical Therapy, Inc. to Report Q2, 2022 Results on Aug 04, 2022

First quarter 2022 earnings released: EPS: US$0.68 (vs US$0.21 in 1Q 2021)

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on June 14, 2022

Insufficient new directors

U.S. Physical Therapy, Inc. to Report Q1, 2022 Results on May 05, 2022

U.S. Physical Therapy, Inc., Annual General Meeting, May 17, 2022

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired a 70% stake in Madden and Gilbert Physical Therapy, LP from Chad Madden, Michael Gilbert and others for $11.5 million.

Independent Director recently sold €287k worth of stock

Chief Operating Officer of East recently sold €171k worth of stock

Upcoming dividend of US$0.41 per share